Table 4.
Vaccine Status (n) | HSIL | CIN 2 | CIN 3 | CIN 2+ | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Unadjusted | Adjusted | Unadjusted | Adjusted | Unadjusted | Adjusted | Unadjusted | Adjusted | |||||||||
RR (95% CI) | P Value | RR (95% CI) | P Value | RR (95% CI) | P Value | RR (95% CI) | P Value | RR (95% CI) | P Value | RR (95% CI) | P Value | RR (95% CI) | P Value | RR (95% CI) | P Value | |
Complete series on schedule 9–14 y (18 975) | Ref | … | Ref | … | Ref | … | Ref | … | Ref | … | Ref | … | Ref | … | Ref | … |
Complete series on schedule 15 + y (1997) | 1.66 (1.12–2.39) | .008 | 1.56 (1.05–2.24) | .02 | 1.58 (.69–3.17) | .23 | 1.39 (.61–2.79) | .40 | 2.02 (.68–4.92) | .16 | 1.84 (.61–4.52) | .22 | 1.72 (.91–3.01) | .07 | 1.53 (.81–2.69) | .16 |
Incomplete series 15+ y (1439) | 2.59 (1.78–3.66) | <.0001 | 2.41 (1.66–3.42) | .02 | 1.64 (.63–3.55) | .26 | 1.47 (.56–3.19) | .38 | 3.91 (1.55–8.71) | .002 | 3.48 (1.37–7.79) | .004 | 2.38 (1.26–4.17) | .004 | 2.13 (1.12–3.73) | .01 |
Abbreviations: CI, confidence interval; CIN, cervical intraepithelial neoplasia; HSIL, high-grade squamous intraepithelial lesion; Ref, reference; RR, relative rate.